Comparison results
| Results: Differences General | ✘Systemic aspergillosis | ✘Tumors of the lacrimal glands | ||||
| Related research | Analogs | Analogs | ||||
| ||||||
| Distinctive symptoms | ||||||
| Register, to see more distinctive signs of diseases and studies | 100% | — | ||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | ||||
| systemic aspergillosis | 98% | — | ||||
| cries a lot | — | 98% | ||||
| lung aspergilloma | 61% | — | ||||
| tumors of the lacrimal glands | — | 85% | ||||
| chronic leukemia | 47% | — | ||||
| has a swelling of the eye | — | 80% | ||||
| acute leukemia | 44% | — | ||||
| malignant arterial hypertension | — | 80% | ||||
| immunodeficiency | 44% | — | ||||
| benign epithelial tumors | — | 73% | ||||
| chronic granulomatous disease | 38% | — | ||||
| exophthalmos | — | 71% | ||||
| leukemia | 38% | — | ||||
| glaucoma | — | 65% | ||||
| skin cancer | 37% | — | ||||
| does not like touching | — | 63% | ||||
| metastases | 33% | — | ||||
| does not tolerate pain | — | 55% | ||||
| abscess | 32% | — | ||||
| benign neoplasms | — | 54% | ||||
| bacteremia | 32% | — | ||||
| vascular tumor | — | 53% | ||||
| a history of organ transplantation | 32% | — | ||||
| hypertension | — | 50% | ||||
| sepsis | 32% | — | ||||
| increased | — | 43% | ||||
| papules | 31% | — | ||||
| cancer | 29% | 49% | ||||
| impaired lung function | 28% | — | ||||
| history of surgery | 35% | 43% | ||||
| blood diseases | 27% | — | ||||
| skin problems | 27% | — | ||||
Instructions
Video 
- Introduce new diseases through 🔍 Search and input on the top panel using
- The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
- The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
- The list changes dynamically depending on the data of the current visit in the selection of therapy .
- Click on the percentageto see the suggestions from the original source.
- By using the service, you agree to user agreement.
